PHARMAGAP INC

Yahoo! Finance: GAP.V NewsLatest Financial News for PHARMAGAP INC.

URL

XML feed
http://finance.yahoo.com/q/h?s=gap.v

Last update

6 min 38 sec ago

July 29, 2010

06:34
PharmaGap Appoints Dr. Ken Sokoll to Lead Cancer Drug Program to Clinical Trials (Marketwire)

July 28, 2010

02:15
PharmaGap Announces Appointment to Clinical Development Group; Search for Chief Operating Officer to Guide Lead Drug to Clinical Trials (Marketwire)

July 26, 2010

16:22
PharmaGap to Expand Board, Add Experienced Clinical Development Executive (Marketwire)

July 25, 2010

16:21
PharmaGap Announces $855,625 Private Placement (Marketwire)

July 23, 2010

01:53
PharmaGap Announces Results of NCI Test Program (Marketwire)

July 22, 2010

14:04
PharmaGap Sees 80% Reduction in Melanoma Cancer Cell Growth in Tests at Memorial Sloan-Kettering Cancer Center; Proceeding to Animal Testing (Marketwire)
04:43
PharmaGap Provides Update on NCI Testing and Development Program (Marketwire)
04:43
PharmaGap Announces $608,800 Private Placement (Marketwire)
04:43
PharmaGap Provides Corporate Update & Announces Financing (Marketwire)
04:43
PharmaGap Reports That GAP-107B8 Showed Strong and Consistent Anti-Cancer Activity in a Wide Range of Cancers in NCI Test (Marketwire)
04:43
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont (Marketwire)
04:43
PharmaGap Advises That NCI Test Results Are Completed and Expected to Be Provided to the Company Shortly (Marketwire)
04:43
Ottawa Hospital Research Institute Testing of PharmaGap's Novel Cancer Drug Formally Underway (Marketwire)
04:43
Results from NCI Five-Dose Study of PharmaGap Cancer Drug Expected Late September (Marketwire)
04:43
PharmaGap Releases Compelling Results for Gap-107B8 From the U.S. National Cancer Institute (Marketwire)
04:43
PharmaGap Advised by U.S. National Cancer Institute of Positive Results of Testing for the Company's Lead Cancer Drug GAP-107B8 (Marketwire)

July 21, 2010

07:56
PharmaGap Announces NCI Test Results to be Released in Days (Marketwire)